Objective: To examine in mice the acute effects of epigallocatechin gallate (EGCG), a green tea bioactive polyphenol on substrate metabolism with focus on the fate of dietary lipids. Methods: Male C57BL/6 mice were fed high-fat diets supplemented with EGCG extracted from green tea (TEAVIGO, DSM Nutritional Products Ltd, Basel, Switzerland) at different dosages up to 1% (w/w). Effects of EGCG on body composition (quantitative magnetic resonance), food intake and digestibility, oxidation and incorporation of exogenous lipids (stable isotope techniques:
Introduction
Green tea is one of the most consumed beverages in the world. 1 It contains high levels of polyphenols, whose healthpromoting properties are widely accepted. The main tea polyphenols are catechins whose attributed positive physiological effects include anti-oxidative, anti-carcinogenic, antiinflammatory, anti-viral, anti-bacterial, anti-hypertensive and hypo-cholesterolemic effects. [2] [3] [4] [5] Beyond that, green tea extracts have also been suggested to prevent or reduce obesity. [5] [6] [7] This has been ascribed to the thermogenic action of green tea possibly due to a synergism of caffeine and catechins, which results in an extension of sympathetic stimulation of thermogenesis and thus increased energy expenditure. 6, 8, 9 However, recent evidence suggests that the major green tea catechin epigallocatechin gallate (EGCG) alone is able to decrease body fat accumulation [10] [11] [12] [13] and development of fatty liver in mice fed a high-fat diet. 12, 13 Apparently, the body fat reduction is mainly caused by decreased energy absorption and increased lipid oxidation as shown in animal models 10, 14 and humans 15, 16 although it cannot be excluded that an increase in energy expenditure too small to be measurable might also contribute. We have shown previously that EGCG is able to attenuate the development of high-fat diet-induced obesity in an obesity susceptible mouse model. 10 Although EGCG did not affect energy intake and energy expenditure significantly, energy extraction from food was reduced, and changes in respiratory quotient suggested increased lipid oxidation and/or reduced lipogenesis Analysis of gene expression in liver and white fat (WAT) suggested a reduction of glucose catabolism and lipogenesis, favoring lipid catabolism in turn. 10 However, these data were obtained after 4 weeks of treatment when there were significant differences in body fat accumulation. Therefore, it cannot be excluded that the results were due to the change in body composition rather than the cause for the reduction in body fat. Also, the bioavailability of EGCG is rather low 2, 17 making it questionable if peripheral concentrations of EGCG reach high enough levels to cause direct effects on adipose tissue differentiation and metabolism as suggested from in vitro studies. [18] [19] [20] [21] In this study we aimed to investigate EGCG effects on the fate of dietary lipids after short-term treatment before body weight and body fat are affected. Male C57BL/6 mice were fed with semi synthetic high-fat diets supplemented with EGCG (TEAVIGO) at different doses for up to 8 days. We evaluated the effects of dietary administered TEAVIGO on energy balance, plasma parameters, exogenous fatty acid oxidation, dietary fat incorporation into different organs and tissues and gene expression in intestinal mucosa and liver.
Methods
Animal maintenance and experimental setup Male C57BL/6N mice were purchased from Charles River (Sulzfeld, Germany) at an age of 10-12 weeks. Animals were housed individually, under standard conditions at 22 1C and a 12 h:12 h dark-light cycle with food and water provided ad libitum throughout the experiments. Animal maintenance and experiments were in accordance with the guidelines of the ethics committee of the Ministry of Environment, Health, and Agriculture (State Brandenburg, Germany). Before the experiments, mice were fed a standard rodent chow diet containing (w/w) 19% protein, 3.3% fat and 41.2% carbohydrates (V-1534-0, ssniff Spezialdiäten GmbH, Soest, Germany) provided as pellets. At the beginning of the experiments, mice were randomly divided into the experimental groups and shifted to one of two different semisynthetic high-fat (HF) diets 22 (see Supplementary Table 1 for diet composition) with or without dietary EGCG (TEAVIGO) supplementation at different dosages as described below. TEAVIGO (DSM Nutritional Products Ltd, Basel, Switzerland) is an extract of green tea (Camellia sinensis), which contains over 94% of EGCG and less than 0.1% caffeine.
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Experiment 1. In this study we investigated short-term effects of EGCG on exogenous palmitate oxidation as well as liver triglyceride and glycogen content under postabsorptive and post-prandial conditions. Mice were fed a semi-synthetic HF diet containing 40 energy% fat mainly in form of palm kernel fat (see Supplementary Table 1 for diet composition) for 4 days with or without dietary TEAVIGO supplementation (control, EGCG 0.5%, EGCG 1.0%; n ¼ 12 per group). Body weight and food intake were determined daily. Acute palmitate oxidation was examined 24 h after the switch to the experimental diets as described below. Mice were killed in the morning of day 5, either after an overnight fast (post-absorptive state, n ¼ 8 per group) or 2-3 h after food withdrawal (post-prandial state, n ¼ 4 per group). Various organs and tissues were dissected and rapidly frozen for biochemical analyses and RNA extraction.
Experiment 2.
In the second experiment, we investigated the incorporation of naturally 13 C-enriched dietary triglycerides from corn oil into various organs and tissues. Mice (n ¼ 8 per group) were fed a semi-synthetic 13 C-enriched HF diet ( 13 C-HF diet, 40 energy% of fat, see Supplementary Table 1 for diet composition) over 8 days containing corn oil as the only fat source. TEAVIGO was applied via the diet at different dosages (0.25 and 0.5% w/w). This resulted in four groups: a control group fed 13 C-high-fat diet ( 13 C-HF diet) without addition and two EGCG supplemented groups fed 13 C-HF diet (EGCG 0.25% and EGCG 0.50%, n ¼ 8). An additional group of mice fed standard rodent chow (SD) were killed at the start of the experiment in order to determine baseline 13 C-enrichment of various tissues (see below). Body weight and body composition was determined before and 7 days after the feeding intervention. Food intake was monitored daily and total feces were collected for analysis of energy excretion and food digestibility. On the morning of day 8, mice were killed after an overnight fast, plasma was collected and the following tissues were dissected and rapidly frozen for determination of 13 C-enrichment and RNA extraction: epididymal white adipose tissue, subcutaneous WAT, visceral (mesenteric) WAT, interscapular brown fat, skeletal muscle (combined muscles of the upper hindleg), liver and intestinal mucosa.
Body composition and energy digestion
Body composition was determined before the start of the experiment (day 0) and at the end of the dietary intervention (experiment 1: day 5, experiment 2: day 8) using quantitative magnetic resonance as described. 10 Energy digestion in experiment 2 was determined by subtraction of energy content in feces from energy content from food consumed. Total energy content in food was measured in duplicate samples of the diets as described. 10 C-enrichment in breath of mice was determined in regular intervals over a period of 300 min. Breath 13 CO 2 enrichments were analyzed by isotope ratio mass spectrometry (BreathMAT.Thermo Scientific, Bremen, Germany) and were expressed as d
13
C in the conventional delta per mill notation as described. 23 Data are expressed as delta over baseline values, which were calculated as the difference between enrichment of each breath sample and the respective baselireferene value of this animal.
Tissue incorporation of dietary fat
Surplus energy is stored in fat depots in the organism, and body fat composition reflects dietary fat intake. 25 We used corn oil as a naturally 13 C-enriched lipid in order to assess incorporation of dietary lipids into various tissues and organ through changes in the 13 C/ 12 C isotope ratio (experiment 2). Corn is a C4-plant, which accumulates a greater amount of the heavier carbon isotope ( 13 C) than C3-plants such as wheat due to isotope discriminations during photosynthesis. Consequently, the consumption of C4-plants results in higher 13 C/ 12 C isotope ratios in breath CO 2 and tissues compared with C3-plants. We have previously shown that naturally enriched 13 C corn oil can be used to determine the post-prandial exogenous fat oxidation in humans. 26 Mice were shifted from a standard rodent chow diet (d 13 C: À23.53%) containing no C4-components to a corn oilcontaining HF diet (d 13 C: À15.95%) with and without EGCG supplementation. Preliminary experiments established that after 7 days of feeding 13 C-enrichment is still increasing nearly linearly in various organs with a new steady state reached after about 4 weeks (data not shown). Therefore, differences in 13 C-enrichment in different tissues after 1 week reflect different amounts of dietary lipid incorporated into these tissues, with higher numerical values indicative of higher lipid turnover and higher incorporation rate of dietary fat into the respective tissue or organ. 13 C enrichment was measured in different fat depots (white adipose tissue, visceral (mesenteric) WAT, subcutaneous WAT and interscapular brown fat) and in skeletal muscle, liver, plasma and feces using EA-isotope ratio mass spectrometry (elemental analyzer-isotope ratio mass spectrometry, Thermo Scientific) as described. 23 Furthermore, breath 13 CO 2 enrichment (reflecting oxidation of exogenous lipids, 26) was determined with isotope ratio mass spectrometry as described above. Isotope ratios were calculated by using the d-notation (d 13 C-values). The delta over baseline values for each sample were calculated as the difference of the mean d
13
C-values of a given tissue of the groups fed the HF diet for 7 days from those of the baseline (SD) group.
Quantitative real-time PCR RNA was isolated from individual mouse tissues (white adipose tissue, liver and intestinal mucosa) and quantitative real-time PCR was performed as described before. 27 See
Supplementary Table 2 for gene-specific primer probe pairs. Gene expression was calculated as DCT using 18S rRNA as reference as described, 27 and expressed relative to the control HF group normalized to a value of one.
Histology
Livers were fixed in 4% buffered formaldehyde, rinsed in phosphate-buffered saline, dehydrated in a graded series of 55-100% ethanol and paraffin embedded. Cryosections of 2 mm were stained using standard procedures for oil red O staining of triglycerids.
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Plasma and tissue measurements Plasma-free fatty acids, total cholesterol and triglycerides as well as liver triglyceride and glycogen analysis were analyzed in triplicates on 96-well plates using commercial colorimetric and enzymatic standard assays as described. 28 
Statistical analysis
Results are expressed as means ± s.e.m. Data were analyzed by analysis of variance followed by Turkey-Kramer post hoc test (GraphPad Prism 5.0, GraphPad Prism Software Inc., San Diego, CA, USA). Differences at Po0.05 were considered significant.
Results

Experiment 1
EGCG supplementation of the HF-diet resulted in a dosedependent decrease in body weight and fat gain compared with the control group after 4 days, whereas lean body mass was not affected. Liver weight and epdidymal fat pad weight were also reduced by 0.5% dietary EGCG. No effects were observed on fat-free body mass, as well as total food and energy intake (Table 1) . Acute EGCG treatment (24 h) led to an increase in the oxidation of orally applied palmitate as evident from increased 13 C enrichment in breath CO 2 during [1- After 4 days feeding mice were killed on day 5 with part of them in the post-absorptive state (fasted over night) and part in the post-prandial state that is in the morning after only 2-3 h food withdrawal. Plasma triglycerides were reduced dose dependently by EGCG, an effect that was much more pronounced in the post-prandial than the Green tea reduces dietary fat incorporation M Friedrich et al post-absorptive state (Table 2) . Similarly, liver triglyceride content was reduced by EGCG in the post-prandial state, but not in the post-absorptive state as evident from liver histology (Figures 2a and b) and from biochemical quantification of liver triglycerides (Figures 2c and d) . Liver glycogen content was also reduced by EGCG, again more pronounced in the post-prandial state (Figures 2e and f) . It should be noted that in control animals, liver glycogen content was over 10 times higher the post-prandial than post-absorptive. Additionally we analysed the expression of lipogenesis-related genes in liver samples of the same animals ( Table 2) . EGCG treatment led to a downregulation of lipogenic genes: acetyl-CoA-carboxylase (ACC), fatty acid synthase (FAS) and stearoyl-CoA desaturase (SCD1), which again was much more pronounced in the post-prandial state in which all three genes were significantly downregulated. In the post-absorptive state a significant downregulation was only evident for SCD1 at a concentration of 1% EGCG (Table 2) .
Experiment 2
No effects of EGCG on body weight, lean body mass or body fat content were observed after feeding a 13 C-HF diet containing corn oil as the only fat source for 8 days (Table 3 ). Comparable to experiment 1, total energy intake was not affected by EGCG, confirming previous results. 10 With regard to plasma lipids, only marginal effects of EGCG were evident, the only significant effect was a slight reduction of plasma non esterified fatty acids (NEFA) in the 0.5% EGCG group compared with control (Table 3 ). Total energy excretion in feces was dose dependently increased by EGCG (Figure 3a ). This was due to increased feces production rather than an increase in weight-specific energy content of feces (data not shown). EGCG also increased the nitrogen excretion in feces (Figure 3b) , and the 13 C enrichment in feces, which is indicative for an increased excretion of dietary lipids (Figure 3c ). Total food digestibility was significantly decreased by EGCG (Figure 3d ). Green tea reduces dietary fat incorporation M Friedrich et al Figure 4 shows the 13 C enrichment in different tissues, plasma and breath CO 2 after feeding a 13 C-HF diet containing corn oil as the only fat source for 8 days. In all fat depots (Figures 4a-d) there was a tendency of decreased 13 C enrichment in the 0.5% EGCG group, indicative of decreased incorporation of dietary lipids. This was most pronounced in the visceral fat (Figure 4b ). The lower control delta over baseline values in epididymal WAT (Figure 5a ) compared with visceral WAT suggest a lower lipid turnover in white adipose tissue compared with the other fat depots. Additionally to the fat depots, 13 C enrichment was also reduced 
Green tea reduces dietary fat incorporation
M Friedrich et al SGLT1 (Figure 5d ) was considerably decreased by the 13 C-HF diet. FATP4 gene expression (Figure 5c ) was also decreased by the 13 C-HF diet, not reaching statistical significance. In the cases when high-fat diet affected gene expression, EGCG treatment dose dependently abolished these changes, resulting in expression levels that were not different from the baseline group fed standard diet.
Discussion
The present study demonstrates that the well established beneficial effects of EGCG on obesity and associated pathologies 6, 10, 29 are apparently linked to its acute and direct effects on energy balance and lipid metabolism. We present evidence that EGCG acts predominantly on metabolism of dietary lipids both by decreasing their absorption and increasing their oxidation. We examined the effects of short-term dietary application of EGCG in order to avoid potential confounding effects of alterations in body composition on energy and lipid metabolism. Indeed, we did not observe major high-fat diets-induced changes in body composition in the two experiments. Nevertheless, in the first experiment 1% EGCG significantly reduced body weight and fat gain after 4 days of treatment. Therefore, in the second experiment the maximum EGCG concentration used was 0.5%, which did not significantly affect body fat after 8 days of treatment. Another difference between the two high-fat diets used in this study was the fatty acid composition. The HF diet in experiment 1 was based on palm kernel fat, containing mainly medium chain saturated fatty acids, whereas the lipid component in experiment 2 was corn oil, which consists mainly of oleic and linoleic acid, that is mono and polyunsaturated fatty acids.
EGCG increases dietary lipid oxidation
Previous data suggested that EGCG is able to increase fatty acid oxidation as evident from decreased respiratory quotient after feeding. 10 However, the respiratory quotient is only an indirect measurement because it represents an outcome of the overall balance of substrate oxidation. Moreover, it does not allow discrimination between endogenous or exogenous (that is dietary) fatty acid oxidation. Therefore, in this study we used two different experimental approaches in order to assess the effect of EGCG on dietary lipid oxidation more specifically. [1-13 C]-palmitate breath tests showed that the oxidation of orally applied [1-13 C]-palmitate was increased by dietary EGCG supplementation after one day of treatment (experiment 1). This increased fatty acid oxidation was confirmed in the second experiment where naturally 13 C-enriched corn oil was used as the only fat source. Breath tests also showed an increased breath 13 CO 2 -enrichment with EGCG supplementation until the fourth day of treatment. Together these data confirm that EGCG acutely increases oxidation of dietary fat. Interestingly, this also seems to be the case in humans. It has been shown that in overweight men EGCG decreased postprandial respiratory quotient, indicative of decreased postprandial fat oxidation. 15, 16 Another study found no effects of short-term EGCG treatment on resting metabolic rate or thermic effect of food in lean humans. 30 
EGCG decreases dietary energy absorption
It has previously been shown that feces energy excretion and thus diet digestibility is decreased by green tea extracts in general 9, 31 and EGCG specifically. 10 This was again confirmed in the present study where we observed a significantly increased energy excretion already at 0.25% dietary EGCG content. This was due to an overall increased feces production rather than an increase in feces energy density suggesting that excretion of all macronutrients could be increased as has been shown previously with a green tea extract in rats. 31 The increase in feces 13 C-enrichment observed in experiment 2 is indicative of an EGCG-induced increased excretion of dietary lipids in line with a previous study in rats, which showed a decreased intestinal cholesterol absorption by EGCG.
14 Polyphenols are known to interact with proteins such as pancreatic enzymes. [32] [33] [34] An increased excretion of dietary lipids by EGCG could possibly be achieved by inhibition of pancreatic lipase in the intestine. 35 Interestingly,
we also found an increased EGCG-induced fecal nitrogen excretion, indicative of increased protein excretion. An increased fecal protein excretion after supplementation of diet with tea catechins has also been shown previously. 31, 36 This could possibly be due to interactions of EGCG with dietary and endogenous proteins. Normally, nitrogen excretion via feces is minor. An increased fecal nitrogen excretion thus suggests that hydrolysis of proteins in the intestinal tract was inhibited by EGCG. Beyond that, interaction of EGCG with digestive enzymes might lead to their functional loss and increased fecal excretion. Interaction of polyphenols with tea catechins can lead to formation of soluble and insoluble proteinpolyphenol complexes. 33 In our study, feces were not analyzed with regard to carbohydrate excretion. But the decreased hepatic glycogen content of EGCG mice in post-prandial state suggests a restricted carbohydrate digestion and reduced absorption in the intestine. It has been shown that tea polyphenols can inhibit alpha-amylase activity 37 and impairment of activity of a-amylase and a-glycosidase induced by tea catechins was suggested to reduce plasma glucose and insulin levels. 32, 34 Recently, Unno et al. 30 showed an increased starch excretion in rats fed tea catechins in their diet.
EGCG decreases tissue incorporation of dietary lipids
We show for the first time that EGCG is able to diminish incorporation of dietary lipids into various organs and tissues. In experiment 2 we used as a fat source corn oil, which is naturally 13 C-enriched compared with standard rodent chow. Previously we have demonstrated that 13 Cenriched corn oil can be used to discriminate between exogenous and endogenous post-prandial fat oxidation in humans. 26 The present study shows that it can also be C-enrichment in plasma of EGCG-treated mice further implies a reduced circulation of diet-derived lipids. This is in line with reduced triglycerides in blood plasma of EGCG supplemented mice as observed in experiment 1 and reported in previous studies with tea catechins. 13, 31, [38] [39] [40] [41] In experiment 2 plasma triglyceride concentrations were overall much lower than in experiment 1, which is most probably due to the different fatty acid composition of the two diets. It is well known that diets high in unsaturated fatty acids lead to lower body fat accumulation and decreased plasma lipids compared with diets high in saturated fatty acids. [42] [43] [44] Feeding of the corn oil containing diet (experiment 2) resulted in lower plasma lipids compared with the HF diet with mainly palm kernel fat as fat source (experiment 1). Reduction of plasma lipids by EGCG was thus evident only in mice fed saturated fatty acids, which strongly increased plasma triglycerides.
EGCG affects post-prandial substrate metabolism
This study shows that the beneficial effects of EGCG on body fat accretion and lipid metabolism are due to a dual action of EGCG, which is mainly evident in the post-prandial state. EGCG acutely decreases intestinal absorption of dietary lipids and increases their oxidation. Together this leads to decreased post-prandial lipid accumulation in liver and in turn to decreased plasma triglyceride concentrations resulting in decreased incorporation of dietary lipids into tissues and organs. The increased oxidation of exogenous fatty acid by EGCG could be due to a decreased carbohydrate uptake in the intestine as evident by decreased post-prandial and postabsorptive liver glycogen content, favoring the use of lipids for oxidation. This suggests that the inhibitory effect of EGCG on intestinal substrate absorption could be crucial for its positive effects on energy metabolism and obesity development. In intestinal mucosa, we analyzed gene expression of proteins involved in fatty acid and glucose transport. Interestingly, EGCG affected only the expression of those genes that were induced (CD36/FAT) or reduced (FATP4, SGLT1) by short-term feeding of a high-fat diet. In these cases, EGCG dose dependently abolished or diminished the high-fat diet-induced effects. This is in accordance with the notion that EGCG decreases the availability of dietary fatty acids for enterocytes. Previous rodent studies have shown that in the long term, tea catechins and EGCG could prevent the development of fatty liver induced by high-fat feeding, 12, 13, 38 and could also attenuate hepatic steatosis in the obese ob/ob mouse model. 30 In this study we show that EGCG reduced liver triglycerids already after 4 days of treatment but only in the post-prandial, that is fed state. Furthermore, liver expression of lipogenic genes (ACC, FAS and SCD1) was dose dependently decreased by EGCG, again more pronounced in the fed state, suggesting a decreased lipid biogenesis. It can be concluded that EGCG acutely affects overall lipid metabolism (i) by reducing intestinal lipid absorption and thus post-prandial increases in liver and plasma triglyceride levels, and (ii) by increasing oxidation of dietary lipids possibly due to decreased availability of dietary carbohydrates. Through this dual action EGCG can reduce body fat accumulation and development of liver steatosis induced by a high-fat diet. All observed short-term effects of EGCG were more pronounced in the fed state than in the fasted state, suggesting that post-prandial effects of EGCG on splanchnic tissues are responsible for the attenuation of obesity and associated disorder induced by high-fat diets.
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